Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Stitch Fix Inc (SFIX) vs Tilray Brands Inc (TLRY) Price & Performance

Stitch Fix IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Stitch Fix Inc vs Tilray Brands Inc — how do they compare? Stitch Fix Inc trades at $2.74 (market cap $366.07M), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and Stitch Fix Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Stitch Fix Inc for 31 Days and Tilray Brands Inc for 31 Days on average.

SFIXTLRY
Market Cap
$366.07M$549.01M
Volume
5,152,0083,292,073
Sector
Consumer CyclicalHealth
52-Week High
$5.64$21.00
52-Week Low
$2.16$3.57
Typical Hold Time
31 Days31 Days
Enterprise Value
$261.88M$716.15M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Stitch Fix Inc

Stitch Fix (SFIX) trades at $2.73, up 2.25% today, but remains under pressure with a bearish technical signal. Recent Q4 2026 earnings showed a narrower loss than expected, but revenue missed estimates and weak FY2027 guidance triggered an 18% stock drop. The company is navigating a challenging consumer environment while leveraging AI personalization to boost engagement. Fundamentals show improving net loss margins, but negative ROE and ROA persist.

The outlook is cautious. While cost controls are improving losses, declining active clients and soft revenue guidance pose headwinds. Analyst consensus is a $3.40 price target with a 'Hold' bias. Key risks include execution on growth initiatives, high client acquisition costs, and ongoing legal investigations. The stock offers speculative appeal if turnaround gains traction, but near-term volatility is likely.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.

While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SFIX
0% Buy100% Sell
Avg holding period · 31 Days
TLRY
100% Buy0% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Stitch Fix Inc

Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.

Read more on SFIX →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →